Literature DB >> 9714471

HLA-DPbeta residue 69 plays a crucial role in allorecognition.

G Díaz1, M Catálfamo, M T Coiras, A M Alvarez, D Jaraquemada, C Nombela, M Sánchez-Pérez, J Arroyo.   

Abstract

To investigate the contribution to allorecognition of the individual polymorphic positions Glu 69 and Val 36 from the DPB1*02012 allele, DPB1*02012 cDNA was subjected to site-directed mutagenesis and alleles expressing Lys at 69 and Ala at 36 were generated. The lymphoblastoid cell line (LCL) 45.EM1, a previously generated mutant B-LCL which expresses normal levels of DPA mRNA but is not able to transcribe DPB, was transfected with wild-type or mutant DPB1*02012 cDNAs. The ability of two HLA-DPw2 alloreactive CD4+ cytotoxic T-lymphocyte (CTL) clones to lyse the panel of DPB1*02012 wild-type and site-directed mutant B-cell lines was tested. Both CTL clones (8.3 and 8.9) lysed the B-LCL 45.1, which is haploid for HLA and expresses wild-type DPB1*02012, and transfectants expressing Ala at 36 instead of Val, indicating that this polymorphic residue is not critical for T-cell recognition. However, the change of Glu to Lys at 69 prevented recognition by clones 8.3 and 8.9. These data demonstrate that the residue at peptide-binding position 69 is crucial for T-cell receptor recognition and suggest the requirement for a negatively charged residue at this position for allostimulation of these T-cell clones. The side chain of DPbeta-69 is predicted to point into the peptide-binding groove, and the existence of positive(Lys) or negative (Glu) residues probably leads to substantial differences in the allo- or auto-DP-bound peptides or to differences in the conformation of the peptide-MHC complex, which would therefore be responsible for specific DPw2 allorecognition. The binding of a panel of monomorphic and polymorphic anti-HLA-DP monoclonal antibodies (mAbs) to these transfectants was also tested by flow cytometry. The changes at Glu 69 and Val 36 did not affect recognition by any of the monomorphic antibodies tested. However, the binding pattern of some of the polymorphic mAbs was clearly modified. Therefore, even though it is not crucial for T-cell allorecognition, polymorphic residue 36 must be involved in epitopes recognized by some polymorphic anti-DP antibodies, while residue 69 of the DPB molecule is crucial both for T-cell allorecognition and recognition by some mAbs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714471     DOI: 10.1111/j.1399-0039.1998.tb03020.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

1.  Extended HLA-DPB1 polymorphism: an RNA approach for HLA-DPB1 typing.

Authors:  Judith Reinders; Erik H Rozemuller; Rogier van Gent; Yvonne H A Arts-Hilkes; Jan G van den Tweel; Marcel G J Tilanus
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

2.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Authors:  Katharina Fleischhauer; Bronwen E Shaw; Theodore Gooley; Mari Malkki; Peter Bardy; Jean-Denis Bignon; Valérie Dubois; Mary M Horowitz; J Alejandro Madrigal; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Stephen Spellman; Andrea Velardi; Elisabetta Zino; Effie W Petersdorf
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316

3.  HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families.

Authors:  Michael D Varney; Ana Maria Valdes; Joyce A Carlson; Janelle A Noble; Brian D Tait; Persia Bonella; Eva Lavant; Anna Lisa Fear; Anthony Louey; Priscilla Moonsamy; Josyf C Mychaleckyj; Henry Erlich
Journal:  Diabetes       Date:  2010-04-27       Impact factor: 9.461

4.  ATPase4A Autoreactivity and Its Association With Autoimmune Phenotypes in the Type 1 Diabetes Genetics Consortium Study.

Authors:  Janet M Wenzlau; Pamela R Fain; Thomas J Gardner; Lisa M Frisch; Bruno Annibale; John C Hutton
Journal:  Diabetes Care       Date:  2015-10       Impact factor: 19.112

5.  Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing.

Authors:  Esteban Arrieta-Bolaños; Pietro Crivello; Maximilian Metzing; Thuja Meurer; Müberra Ahci; Julie Rytlewski; Marissa Vignali; Erik Yusko; Peter van Balen; Peter A Horn; J H Frederik Falkenburg; Katharina Fleischhauer
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

Review 6.  Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.

Authors:  James A Snyder; Ainsley Weston; Sally S Tinkle; Eugene Demchuk
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.